Kent P. Friedman MD

Dr. Friedman is a nuclear medicine physician with fellowship training in PET/CT. My current position is Section Chief for Nuclear Medicine, Department of Radiology at NYU Langone Medical Center (NYULMC). He is Coorganizer of the MR-PET Research Focus Group at NYULMC, providing guidance and leadership for the development of a large number of MR-PET research protocols conducted at NYULMC. Through his work with the MR-PET Research Group I am fostering collaborations with numerous investigators in the Radiology, Oncology, Radiation Oncology, Endocrinology, Surgery, Neurology and Psychiatry Departments.

His primary research interest focuses on how to combine multiple dynamically changing parameters measured on sequential mutimodality scans (PET/CT, SPECT/CT, PET/MR) to best diagnose disease and predict and monitor response to therapies. Projects supporting this general aim include an ongoing analysis of metabolic treatment responses in breast cancer patients, active work in PET and MR responses to anti-angiogenic therapy, and assessment of PET response assessment in radiation therapy among different tumor histologies and treatment regimens.